Chemed Corp. Hits New 52-Week High at $495.83, Marking Key Milestone

Chemed Corp. has reached a significant milestone by hitting a new 52-week high of USD 495.83 on July 13, 2026. This achievement highlights the stock's notable activity within the hospital industry, where Chemed operates as a small-cap company with a market capitalization of USD 12,841 million. Despite the recent high, Chemed Corp. has experienced a 1-year performance decline of 9.65%, contrasting with the S&P 500's gain of 20.06% over the same period. The company's price-to-earnings (P/E) ratio stands at 48.00, indicating a premium valuation compared to its peers. Additionally, Chemed boasts a return on equity of 27.10%, reflecting its efficiency in generating profits from shareholders' equity. The stock also offers a modest dividend yield of 0.27%, and its price-to-book ratio is recorded at 13.11. With a debt-to-equity ratio of -0.02, Chemed maintains a strong balance sheet, positioning itself well within the competitive landscape of the hospital sector. The previous 52-week low for the stock was USD 365.51, marking a significant upward movement in its price trajectory.